Fred Aslan

Chief Executive Officer, Artiva Biotherapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 15, 2026Granted 110,000 shares of Artiva Biotherapeutics, Inc.²
Sep 10, 2026Granted 45,000 shares of Artiva Biotherapeutics, Inc.³
Sep 8, 2026Sold 23,429 shares at $10.92 of Artiva Biotherapeutics, Inc.⁴
Sep 3, 2026Sold 61,888 shares at $11.16 of Artiva Biotherapeutics, Inc.⁵
May 19, 2026Sold 27,116 shares at $9.01 of Artiva Biotherapeutics, Inc.⁶
Feb 15, 2026Shares withheld for tax 14,600 shares at $4.00 of Artiva Biotherapeutics, Inc.⁷
Feb 15, 2026Granted 366,850 shares of Artiva Biotherapeutics, Inc.⁷
Dec 15, 2025Sold 3,187 shares at $6.00 of Artiva Biotherapeutics, Inc.⁸
Dec 12, 2025Granted 869,136 shares of Artiva Biotherapeutics, Inc.⁹
Nov 17, 2025Sold 6,375 shares at $3.38 of Artiva Biotherapeutics, Inc.¹⁰
Nov 15, 2025Shares withheld for tax 6,347 shares at $3.25 of Artiva Biotherapeutics, Inc.¹⁰
Oct 17, 2025Sold 25,500 shares at $6.00 of Artiva Biotherapeutics, Inc.¹¹
Aug 15, 2025Shares withheld for tax 4,472 shares at $2.75 of Artiva Biotherapeutics, Inc.¹²
Aug 15, 2025Sold 25,500 shares at $2.73 of Artiva Biotherapeutics, Inc.¹²
May 15, 2025Shares withheld for tax 4,472 shares at $2.13 of Artiva Biotherapeutics, Inc.¹²
Mar 5, 2025Granted 200,000 shares of Artiva Biotherapeutics, Inc.¹³
Jul 22, 2024Granted 228,905 shares of Artiva Biotherapeutics, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.